1. Home
  2. RBCAA vs EVO Comparison

RBCAA vs EVO Comparison

Compare RBCAA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBCAA
  • EVO
  • Stock Information
  • Founded
  • RBCAA 1974
  • EVO 1993
  • Country
  • RBCAA United States
  • EVO Germany
  • Employees
  • RBCAA N/A
  • EVO N/A
  • Industry
  • RBCAA Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBCAA Finance
  • EVO Health Care
  • Exchange
  • RBCAA Nasdaq
  • EVO Nasdaq
  • Market Cap
  • RBCAA 1.3B
  • EVO 1.4B
  • IPO Year
  • RBCAA 1998
  • EVO 2021
  • Fundamental
  • Price
  • RBCAA $68.63
  • EVO $3.98
  • Analyst Decision
  • RBCAA
  • EVO Buy
  • Analyst Count
  • RBCAA 0
  • EVO 2
  • Target Price
  • RBCAA N/A
  • EVO $5.90
  • AVG Volume (30 Days)
  • RBCAA 25.3K
  • EVO 200.1K
  • Earning Date
  • RBCAA 07-18-2025
  • EVO 05-06-2025
  • Dividend Yield
  • RBCAA 2.63%
  • EVO N/A
  • EPS Growth
  • RBCAA 27.18
  • EVO N/A
  • EPS
  • RBCAA 5.97
  • EVO N/A
  • Revenue
  • RBCAA $358,928,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • RBCAA $2.40
  • EVO $10.08
  • Revenue Next Year
  • RBCAA $3.62
  • EVO $10.99
  • P/E Ratio
  • RBCAA $11.48
  • EVO N/A
  • Revenue Growth
  • RBCAA 15.04
  • EVO 1.50
  • 52 Week Low
  • RBCAA $48.67
  • EVO $2.84
  • 52 Week High
  • RBCAA $80.68
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • RBCAA 43.93
  • EVO 49.18
  • Support Level
  • RBCAA $68.83
  • EVO $3.78
  • Resistance Level
  • RBCAA $74.06
  • EVO $4.05
  • Average True Range (ATR)
  • RBCAA 1.36
  • EVO 0.15
  • MACD
  • RBCAA -0.73
  • EVO -0.04
  • Stochastic Oscillator
  • RBCAA 21.97
  • EVO 19.61

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: